Latest news

• Sanofi/GSK vaccine boosts immune response

  Roger Connor, president of GSK Vaccines, added: “As the pandemic threat continues with the current dominant Delta variant and Omicron rapidly gaining ground, booster vaccines will continue to be needed to ... The 10, 000 participants will receive two

• South Africa releases first real-world evidence for Omicron

  However, the risk of hospital admission for adults was 29% lower for Omicron than for the Delta variant, even after adjusting for vaccination status. ... Discovery Health CEO Dr Ryan Noach said that  genetic surveillance in South Africa had identified

• Omicron rise prompts tougher measures in England

  Data suggested that new infections with the Omicron variant were doubling every three days and that it was highly likely that Omicron would replace Delta as the dominant variant within ‘a ... Several data sources point to Omicron possessing a clear

• Mix-and-match COVID-19 vaccines may be more effective

  As booster campaigns against COVID-19 across the world are ramped up to combat a new wave of Delta variant and the threat of the new Omicron variant, data is trickling ... SARS-CoV-2 strain and both the Delta and Beta variants four weeks following the

• Lilly’s combination antibody expanded to children under 12

  Lilly has performed ‘pseudovirus and authentic virus studies’ to confirm that the treatments retain activity against the dominant Delta variant of concern and is ’working quickly’ to understand its effect against ... the Omicron variant of concern